Latest news
Solid Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Updates - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 20:35:35 GMTLandmark Phase III Trial Finds Cell Therapy Slows Muscle Decline in Advanced DMD - Genetic Engineering and Biotechnology NewsGenetic Engineering and Biotechnology News · Wed, 29 Jul 2026 19:26:16 GMTPhase 3 trial shows investigational cell therapy slowed disease progression in Duchenne muscular dystrophy - UC Davis HealthUC Davis Health · Wed, 29 Jul 2026 17:06:09 GMTCapricor Therapeutics Announces Lancet Publication of Positive Phase 3 HOPE-3 Trial Results for Deramiocel in Duchenne Muscular Dystrophy - Quiver QuantitativeQuiver Quantitative · Wed, 29 Jul 2026 14:10:00 GMTDMD Potential Therapy Preserves Heart, Arm Function - Cedars-SinaiCedars-Sinai · Wed, 29 Jul 2026 07:00:00 GMTDMD Cell Therapy Delays Disease Progression in Phase III Trial - Inside Precision MedicineInside Precision Medicine · Wed, 29 Jul 2026 07:00:00 GMTFDA Disputes Capricor's Phase 3 Efficacy Claims for Duchenne Cell Therapy Deramiocel - BioPharm InternationalBioPharm International · Tue, 28 Jul 2026 21:36:02 GMTUPDATE: FDA disputes Capricor’s claims of Phase 3 success for DMD cell therapy - BioSpaceBioSpace · Mon, 27 Jul 2026 07:00:00 GMT